Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pharyngitis

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...

Epistaxis

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Tonsillitis II: Management

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transformative Advances in the Treatment of Melanoma: A Review.

Current cancer drug targets·2026

Same author

Circumferential ALIF Provides Superior Sagittal Alignment and Lower Reoperation Rates Than TLIF in Patients ≤50 Years Undergoing Lumbar Interbody Fusion.

Spine·2026

Same author

Alpha 2A adrenergic receptor antagonism reduces fibrosis, inflammation and portal hypertension in models of chronic liver disease.

JHEP reports : innovation in hepatology·2026

Same author

Trends in Female Representation Across Five Competitive Surgical Specialties (2013-2025): A Call for Sustained Equity Efforts.

World journal of surgery·2026

Same author

Heterocyclic Derivatives in Parkinson's Therapy: Recent Advances and Prospects.

Medicinal chemistry (Shariqah (United Arab Emirates))·2026

Same author

Surgical and hormonal gender-affirming care: cross-domain determinants and artificial intelligence-enabled expansion.

International journal for equity in health·2026

Same journal

Osteoradionecrosis of the Scalp: A Case Series Highlighting Clinical Challenges and Literature Gaps.

OTO open·2026

Same journal

Voice Outcomes of Patients Intubated for Critical COVID Illness: A Multicenter Study.

OTO open·2026

Same journal

Development and Evaluation of the Adenoid/Nasopharynx Area Ratio on Lateral Cephalograms: Correlation With Nasal Endoscopy.

OTO open·2026

Same journal

Comprehensive Analysis and Genetic Insights Into GJB2 c.35delG Mutation-Associated Non-Syndromic Hearing Loss in Morocco.

OTO open·2026

Same journal

The Use of Contralateral AEA-Pedicled Septal Flap Combined With HBF for Complex Skull Base Defects.

OTO open·2026

Same journal

Aging and Hearing with Vestibular Schwannoma Beyond Presbycusis: A Large Cross-Sectional Audiometric and Volumetric Study.

OTO open·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 21, 2025

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

Smoking Pack Years and Eustachian Tube Dysfunction.

Arjun Sharma¹, Sam MacDowell¹, Nihal Punjabi^2,3

¹School of Medicine California University of Science and Medicine Colton California USA.

|July 8, 2024

Summary

This summary is machine-generated.

Smoking significantly increases the risk of developing obstructive eustachian tube dysfunction (OETD). Smokers had double the risk, with higher pack-year histories showing increased odds of OETD.

Keywords:

eustachian tube dysfunction risk factors smoking

More Related Videos

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

Related Experiment Videos

Last Updated: Jun 21, 2025

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

Area of Science:

Otolaryngology
Public Health
Epidemiology

Background:

Obstructive eustachian tube dysfunction (OETD) affects middle ear pressure.
Smoking is a known risk factor for various respiratory and cardiovascular conditions.
The specific impact of smoking history on OETD risk requires further investigation.

Purpose of the Study:

To investigate the association between smoking history and the risk of developing obstructive eustachian tube dysfunction (OETD).

Main Methods:

A cross-sectional review of national database data from the National Health and Nutrition Examination Survey (1999-present).
OETD was defined by middle ear pressure < -100 decapascal (daPa).
Relative risks (RRs) were calculated for smokers vs. nonsmokers and varying pack-year (py) thresholds (10+, 20+, 30+ py), excluding specific patient groups.

Main Results:

Analysis included 9472 eligible patients, with 20.3% identified as smokers.
Smokers had a 1.75 times higher risk of OETD compared to nonsmokers (95% CI: 1.45-2.11).
Patients with 10+, 20+, and 30+ pack-years showed increased OETD risk (RRs: 1.97, 2.29, 2.08, respectively).

Conclusions:

Smoking approximately doubles the risk of developing OETD, indicated by negative middle ear pressure.
The study's OETD definition was limited by excluding symptomology.
Findings suggest a need for further research and may inform patient counseling and screening for OETD.